This report focuses on the global Mycoplasma Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mycoplasma Diagnostics development in United States, Europe and China.
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
In 2017, the global Mycoplasma Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Agilent Technologies, Inc
Thermo Fisher Scientific Inc
Charles River Laboratories International, Inc
Takara Bio Inc (Takara Holding Company Inc.)
Tecan Trading AG (Tecan Group)
Sartorius Stedim BioOutsource Limited
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Market segment by Type, the product can be split into
Kits & Reagents
Software & Services
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Mycoplasma Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Mycoplasma Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Mycoplasma Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.